These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 6982847)

  • 1. An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.
    Lala PK; McKenzie IF
    Immunology; 1982 Dec; 47(4):663-77. PubMed ID: 6982847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 3. Analysis of murine oncofetal antigens as tumor-associated transplantation antigens.
    Chism SE; Wallis S; Burton RC; Warner NL
    J Immunol; 1976 Nov; 117(5 Pt.2):1870-7. PubMed ID: 993583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
    J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of general and tumor-specific cell-mediated immune responses in mice bearing progressively growing plasmacytomas.
    Padarathsingh ML; McCoy JL; Dean JH; Lewis DD; Northing JW; Law LW
    J Natl Cancer Inst; 1977 Jun; 58(6):1701-7. PubMed ID: 301196
    [No Abstract]   [Full Text] [Related]  

  • 6. Characterization of a cloned ultraviolet radiation (UV)-induced suppressor T cell line that is capable of inhibiting anti-UV tumor-immune responses.
    Roberts LK
    J Immunol; 1986 Mar; 136(5):1908-16. PubMed ID: 2936813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor immunity to murine plasma cell tumors. I. Tumor-associated transplantation antigens of NZB and BALB-c plasma cell tumors.
    Röllinghoff M; Rouse BT; Warner NL
    J Natl Cancer Inst; 1973 Jan; 50(1):159-72. PubMed ID: 4571237
    [No Abstract]   [Full Text] [Related]  

  • 8. Preferential generation of killer or helper T-lymphocyte activity directed to the tumour-associated transplantation antigens.
    Fujiwara H; Hamaoka T; Teshima K; Aoki H; Kitagawa M
    Immunology; 1976 Aug; 31(2):239-48. PubMed ID: 1085283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological enhancement of tumor growth by syngeneic thymus-derived lymphocytes.
    Umiel T; Trainin N
    Transplantation; 1974 Sep; 18(3):244-50. PubMed ID: 4608685
    [No Abstract]   [Full Text] [Related]  

  • 10. [Method of efficacious immunization against syngeneic murine sarcoma].
    Schaaf-Lafontaine N; Maquet P; De Graef-Lovens D; Courtoy R; Firket H
    C R Seances Soc Biol Fil; 1985; 179(1):122-7. PubMed ID: 3161594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell-mediated immunity in vitro against syngeneic mouse plasma tumour cells.
    Wagner H; Röllinghoff M
    Nat New Biol; 1973 Jan; 241(106):53-4. PubMed ID: 4540590
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of tumor-associated transplantation antigens of sublines of methylcholanthrene-induced murine tumors passaged separately in vivo for over a decade.
    Hines DL
    Cancer Res; 1986 Oct; 46(10):4921-6. PubMed ID: 3489516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
    Cihak J; Ziegler HW; Kölsch E
    Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helper factor(s) augment in vitro induction of tumor-specific immunity.
    Burton RC; Plate JM
    Cell Immunol; 1981 Mar; 58(2):225-37. PubMed ID: 6783322
    [No Abstract]   [Full Text] [Related]  

  • 15. Cell-mediated immune responses to syngeneic tumors. I. Identification of two distinct CTL effector pathways which differ in antigen specificity, genetic regulation, and cell surface phenotype.
    Lynch DH; Daynes RA; Hodes RJ
    J Immunol; 1986 Feb; 136(4):1521-7. PubMed ID: 2418117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.
    Rosenstein M; Eberlein TJ; Rosenberg SA
    J Immunol; 1984 Apr; 132(4):2117-22. PubMed ID: 6607955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In situ characterization of immunologically competent cells during the growth of a transplanted murine sarcoma].
    De Graef-Lovens D; Schaaf-Lafontaine N; Boniver J
    C R Seances Soc Biol Fil; 1985; 179(1):128-36. PubMed ID: 3161595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of tumour-specific immunity V. Detection of common antigenic determinatnts of murine fibrosarcomas.
    Burton RC; Warner NL
    Br J Cancer; 1978 Feb; 37(2):159-70. PubMed ID: 75739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Differences in the expression of a differentiation antigen of activated cells (ACA-1) on T killer cells and on MIF-producing cells].
    Nesterenko VG; Egorova SG; Suslov AP
    Biull Eksp Biol Med; 1983 Jan; 95(1):68-9. PubMed ID: 6338956
    [No Abstract]   [Full Text] [Related]  

  • 20. Establishment of a continuous T cell line capable of suppressing anti-tumor immune responses in vivo.
    Roberts LK; Spellman CW; Warner NL
    J Immunol; 1983 Jul; 131(1):514-9. PubMed ID: 6223081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.